Careers in health don’t stay the same. They can’t. Medicine moves. Tech evolves. People live longer. They also get sicker in new ways. Old treatments stop working. New diseases pop up. It’s constant motion. So what a nurse or therapist did twenty years ago isn’t always what they’re doing now. Some parts stay. But most […]
The post How Careers in Health Change Over Time appeared first on Medical News Bulletin.
Wellness doesn’t start in adulthood. It starts long before that. But most people don’t think about it until things break down. Until anxiety sets in. Until pain sticks around. Until life starts feeling heavier than it should. By then, fixing it is harder. Sometimes really hard. Early intervention doesn’t stop every problem. That’d be unrealistic. […]
The post Early Intervention and Its Role in Lifelong Wellness appeared first on Medical News Bulletin.
Choosing a health career sounds like something people do with total clarity. Like they always know. Like it all makes sense. But that’s not really true. Not most of the time. The truth is, many start out just guessing. And then hope the guess works out. A few read the job descriptions. Some ask around. […]
The post What to Know Before Choosing a Health Career appeared first on Medical News Bulletin.
Okyo Pharma appointed Robert J. Dempsey to serve as the company’s next CEO, according to a press release.
Dempsey has more than 20 years of experience in global ophthalmology and has held leadership roles at several companies. As group vice president and head of global ophthalmology at Shire, Dempsey led the launch of Xiidra (lifitegrast ophthalmic solution 5%, Bausch + Lomb) and its eventual sale to Novartis in 2019, according to the release.
Okyo said the move will support the company’s strategic direction as it advances urcosimod for the treatment of neuropathic corneal pain and ocular
Patients who are prescribed antibiotics during immune checkpoint blockade therapy for solid tumors face a heightened risk for immune-related cutaneous adverse events, according to a research letter published in JAMA Dermatology.
Immune checkpoint blockade (ICB) therapies are increasingly improving cancer survival worldwide, yet many patients develop skin rashes as adverse immune responses to the therapy, according to Lukas Krähenbühl, MD, head physician in the department of dermatology at Kantonsspital Aarau, Aarau, Switzerland and visiting fellow in the Swim Across America and Ludwig
IOP measurements taken at home with the iCare Home2 tonometer correlated closely with in-office measurements, according to a study published in Clinical Ophthalmology.
Most patients used the device multiple times per day, with significant swings in IOP occurring outside of clinic hours.
“In-office IOP monitoring provides only limited IOP surveillance, missing clinically relevant peaks and fluctuations that occur outside of office hours or from day to day,” Scott W. Perkins, a medical student at Cleveland Clinic Lerner College of Medicine, and colleagues wrote. “The iCare Home
An Ohio State University survey of 1,004 individuals showed 72%, 69% and 66% were unaware that knee, groin or thigh pain, respectively, can be a sign of hip osteoarthritis.
“Most patients do not equate thigh or medial knee pain with anything to do with their hip. Most people will equate it to a groin pull, especially your younger patient population. It doesn’t even cross their mind that is it an arthritic problem,” Matthew Beal, MD, associate professor and division chief for adult reconstructive surgery at The Ohio State University Wexner Medical Center, told Healio.
According
Adherence to a structured lifestyle intervention was nonsuperior to a self-guided intervention regarding impact on Alzheimer’s disease-related imaging biomarkers at 2 years among a sub-cohort of older adults in the U.S. POINTER study.
U.S. POINTER Imaging represents “the first large-scale randomized controlled clinical trial involving neuroimaging in a substantial multisite U.S. cohort with a behavioral intervention,” Susan M. Landau, PhD, principal study investigator and neuroscientist at the University of California, Berkeley, told Healio about the data presented at CTAD.
COVID-19 vaccination reduced the risk for severe illness in pregnant patients as well as preterm birth and stillbirth, according to a study of nearly 20,000 pregnancies published in JAMA.
The data “provide clear, population-level evidence that COVID-19 vaccination protects pregnant people and their babies from serious complications,” Deborah Money, MD, a professor of OB/GYN at the University of British Columbia (UBC) in Canada and the study’s senior author, said in a press release. “Even as the virus evolved, vaccination continued to offer substantial benefits for both
Severe valvular heart disease was not uncommon among patients with cancer, and intervention to manage the valvular disease was associated with significant improvement in survival, a speaker reported.
Among patients with cancer and severe valvular heart disease, only about one in five underwent intervention, according to a presentation.
The results of the large-scale observational cohort CESAR study to better understand the prevalence, management and outcomes of valvular heart disease among patients with cancer were presented at the European Association of Cardiovascular Imaging Congress.